Search Results - "Valdés Delgado, Teresa"
-
1
Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing
Published in Therapeutic advances in gastroenterology (01-01-2023)“…Background: Ustekinumab (UST) is indicated for the treatment of Crohn’s disease (CD) and Ulcerative Colitis (UC). Despite having shown clinical effectiveness…”
Get full text
Journal Article -
2
Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori
Published in Revista española de enfermedades digestivas (01-02-2022)“…the primary goal of this study was to compare gastrointestinal symptom reduction in patients on bismuth-containing quadruple eradication therapy supplemented…”
Get full text
Journal Article -
3
Perianal Paget's disease
Published in Revista española de enfermedades digestivas (01-08-2023)“…The incidence of extramammary Paget's disease (EMPD) is very low. It is very important to distinguish between primary Paget's disease and secondary to another…”
Get full text
Journal Article -
4
Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease
Published in Therapeutic advances in gastroenterology (01-01-2024)“…The success of anti-tumor necrosis factor (TNF) drug strategies in the treatment of inflammatory bowel disease (IBD) is altered by the development of anti-drug…”
Get full text
Journal Article -
5
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
Published in Revista española de enfermedades digestivas (01-05-2022)“…ustekinumab is a monoclonal antibody that inhibits interleukins IL-12 and IL-23, and is approved for the treatment of Crohn's disease (CD) and, more recently,…”
Get full text
Journal Article -
6
High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease
Published in Therapeutic advances in gastroenterology (01-01-2024)“…Ustekinumab (UST) is an effective treatment option in Crohn's disease (CD) and ulcerative colitis (UC). However, it still remains unclear if therapeutic drug…”
Get full text
Journal Article -
7
Cut-off ranges of infliximab serum levels in Crohn's disease in the clinical practice
Published in Revista española de enfermedades digestivas (01-10-2020)“…between 30 % and 40 % of patients treated with infliximab lose response during maintenance. Therapeutic drug monitoring could be used to optimize management in…”
Get full text
Journal Article -
8
Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing
Published in Inflammatory bowel diseases (31-07-2024)“…Ustekinumab (UST) is commonly used to treat Crohn's disease and ulcerative colitis. However, some patients may experience diminishing response or require…”
Get full text
Journal Article -
9
Erythema Nodosum: As an Extraintestinal Manifestation or Complication in Ulcerative Colitis?
Published in Inflammatory bowel diseases (18-06-2020)“…Abstract In our case, we want to highlight the importance of screening for opportunistic infectious diseases in these immunosuppressed patients. We present the…”
Get full text
Journal Article -
10
Preliminary experience of the use of a self-expanding nititol stent in refractory variceal bleeding: a real-world study
Published in Revista española de enfermedades digestivas (01-09-2024)“…The fully-covered self-expanding metal stent (SEMS) has a role in the management of refractory acute variceal haemorrhage. The aim of this study was to…”
Get full text
Journal Article -
11
Persistent gastrointestinal bleeding: a diagnostic challenge
Published in Revista española de enfermedades digestivas (01-01-2022)“…Zollinger Ellison syndrome is an unusual entity. This termn is used to describe the clinical manifestations of a gastrin-synthesizing neoplasm. Gastrinomas…”
Get full text
Journal Article -
12
Ischemic gastritis and severe diabetic ketoacidosis
Published in Revista española de enfermedades digestivas (01-08-2021)“…Ischemic gastritis is an extremely rare entity due to the rich gastric vascularization. The case we are going to present could be the ideal setting to suspect…”
Get full text
Journal Article -
13
Double strangeness: Young male with intestinal obstruction secondary to gastrointestinal follicular lymphoma
Published in Revista española de enfermedades digestivas (01-08-2021)“…Follicular lymphoma (FL), a common nodal lymphoma, is rare in the gastrointestinal (GI) tract with few reports. Highlight that this rare entity appeared in a…”
Get full text
Journal Article -
14
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
Published in Revista española de enfermedades digestivas (01-09-2018)“…infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of biosimilar treatments such as CT-P13 will hopefully improve the…”
Get full text
Journal Article -
15
Visceral Leishmaniasis Infection in a Patient with Crohn’s Disease Treated with Azathioprine
Published in Journal of Crohn's and colitis (01-10-2017)Get full text
Journal Article -
16
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
Published in Therapeutic advances in gastroenterology (01-06-2019)“…Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated with CT-P13, an infliximab…”
Get full text
Journal Article -
17
Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis
Published in Inflammatory bowel diseases (01-07-2022)Get full text
Journal Article -
18
Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA
Published in Digestive diseases and sciences (01-01-2024)“…Background Therapeutic drug monitoring of infliximab levels in patients with inflammatory bowel disease (IBD) optimizes patients’ treatment. The reference…”
Get full text
Journal Article -
19
Severe outbreak of ulcerative colitis and cerebral neoplasia. Difficult management in COVID times
Published in Revista española de enfermedades digestivas (01-01-2023)“…A 61-year-old male diabetic patient, diagnosed with ulcerative colitis (UC) 30 years ago, currently under treatment with mesalazine is presented. He was…”
Get full text
Journal Article -
20
GIST. Duodenopancreatectomía. Tumor neuroendocrino no funcionante
Published in Revista española de enfermedades digestivas (01-08-2022)Get full text
Journal Article